Introduction
============

Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death all over the world, with China alone accounting for more than 50% of the total number of cases and deaths [@B1]-[@B3]. Fewer than 20% of patients with HCC are amendable to curative surgical resection and liver transplantation [@B4]. Most patients presented with advanced staged HCC were treated with loco-regional therapies (LRT) or only supportive care. Despite the availability and improvement of different therapies, overall survival of patients with HCC remains poor with an overall 1-year survival rate of less than 50% [@B5].

Despite the substantial advances in knowledge concerning risk factors of patient survival including demographic, tumor- and treatments-related factors, socioeconomic inequalities which persist in cancer incidence, morbidity, mortality, and survival, have been largely neglected [@B6]-[@B8]. Some socioeconomic factors, such as education and household income, can be closely related to comorbidity status, health awareness and adherence to treatments, which are also likely to affect the timing of referral, tumor stage at diagnosis and treatment choices after diagnosis. Some studies have implied that higher education level and household income were associated with a beneficial effect of survival of certain cancer patients [@B6], [@B9]-[@B12]. However, some studies indicated that the effects of socioeconomic status might be restricted in some high-mortality cancers [@B11], [@B13].

As a type of malignancy with high mortality associated, HCC has not been thoroughly studied about potential influence of socioeconomic status on diagnosis, treatments and prognosis. One study using Surveillance, Epidemiology and End Results (SEER) database demonstrated that higher income, longer education and living in large urban areas were correlated with prolonged survival of patients with unresectable HCC [@B14]. However, HCC staging (Barcelona Clinic Liver Cancer \[BCLC\]) and actual treatments were unavailable in the study [@B14]. Therefore, the present study aimed to identify whether socioeconomic disparities as measured by education and household income affect BCLC stages at diagnosis, receipt of treatments, and overall survival among patients with HCC.

Patients and Methods
====================

1622 patients firstly diagnosed as HCC January 2008 to September 2013 in our hospital were included retrospectively. The demographic information, Child-Pugh class, hepatitis status and residence place were documented before the primary treatments. Primary treatments were defined as liver transplant and surgical resection when the patients underwent liver transplant surgical resection during follow up regardless of other treatments received. LRT included radiofrequency ablation, microwave ablation, ethanol intratumoral injection, transarterial chemoembolization (TACE) and palliative resection. Supportive treatments were defined as those with no tumor-target therapy but only nutritional support or no specific treatments.

The education level and household income were reported by the patients or their family members, and documented during follow up. The information was obtained with the understanding of the patients and/or their relatives that it might be published with no identified personal information. The education level were classified as below high school level (less than 9 years of education), high school level (10-12 years of education), and above high school level (≥ 13 years of education). The household income included the self-reported annual income of the patients and their spouses, which were categorized as low income (≤ 50,000 Chinese Yuan \[CNY\]), moderate income (50,000-200,000 CNY) and high income (\>200,000 CNY).

15 patients younger than 25 years old were excluded, since they were still studying in school and had no personal income yet. 122 patients unresponsive to the education and income information were excluded. Finally, 1485 patients were included in the present study. The study has been approved by the ethics committee of the First Affiliated Hospital Xi\'an Jiaotong University. A waiver of informed consent was obtained, since the data were analyzed from the electronic medical record and reported without personal identifiers.

Statistical analysis
--------------------

Numerical variables were expressed as mean ± standard deviation, and compared with One-way ANOVA test among the groups, and with student t test or Mann-Whitney U test between the two groups. Nominal variables were expressed as number and percentages, and compared with Chi-squared test or Fisher\'s exact test. Kaplan-Meier survival analysis was used to compare survival with log-rank test among the three groups and between any two groups. Cox regression was used to assess the association of potential risk factors including education and income of overall survival expressed by hazard ratio (HR) and 95% confidence interval (CI). Two-tailed *p* value \<0.05 was considered statistically significant. Statistical analysis was carried out using SPSS 22.0 (Chicago, IL, USA).

Results
=======

Correlation of education level with clinical parameters
-------------------------------------------------------

Among the 1485 patients, most (60.7%) had education for 10 to 12 years equal to high school level, 21.1% were educated for more than 13 years, and 18.1% for less than 9 years. Patients educated below high school level were older, more female involved, less paid, more living in rural places, and less curatively or loco-regionally treated with a higher 90-day mortality than other two groups, respectively (all *p*\<0.05, Table [1](#T1){ref-type="table"}). Child-Pugh class of liver function was similar among the three groups. However, patients educated for at least 13 years equal to college level were much more highly paid and more likely to live in large cities than other two less educated groups (all *p*\<0.05, Table [1](#T1){ref-type="table"}). Patients educated above high school level were more likely to have early BCLC staged HCC at diagnosis, and receive curative and loco-regional therapies than other two groups (all *p*\<0.05, Table [1](#T1){ref-type="table"}).

Correlation of household income with clinical parameters
--------------------------------------------------------

The self-reported annual household income was categorized as low, moderate and high in 1476 patients (9 patients declined to report their household incomes). Patients with low income were less educated, more likely to live in rural places and had more advanced BCLC stages of HCC than either moderate or high income patients (all *p*\<0.05, Table [2](#T2){ref-type="table"}). Moreover, patients with low income were less treated (although not statistically different) and displayed higher 30-day mortality than other two groups (both *p*\<0.05, Table [2](#T2){ref-type="table"}). Patients with high income had better liver function classified by Child-Pugh score at admission, and were more likely to live in large cities than those with low and moderate income (all *p*\<0.05, Table [2](#T2){ref-type="table"}).

Socioeconomic factors and patients survival
-------------------------------------------

The overall 1-, 3- and 5-year survival rates of all the patients were 77%, 43% and 20%, respectively. The survival curves of the patients at different education level were plotted by Kaplan-Meier method in Figure [1](#F1){ref-type="fig"}A. Patients educated above high school had significant prolonged survival than those educated at or below high school level (Median survival 47 vs. 37 months,*p*=0.028; and 47 vs. 35 months, *p*=0.010) (Figure [1](#F1){ref-type="fig"}A). The 1-, 3- and 5-year survival rates were 72%, 41% and 17% in patients educated below high school, 78%, 43% and 17% at high school level, and 81%, 47% and 31% above high school level, respectively (*p*=0.019, , Figure [1](#F1){ref-type="fig"}A).

When stratified by household income, patients with high income had significantly better prognosis than other two groups (Median survival, 46 months vs. 37 months and 34 months, *p*=0.003 and *p*\<0.001, respectively) (Figure [1](#F1){ref-type="fig"}B). The 1-, 3- and 5-year survival rates were 75%, 39% and 14% in patients with low income, 77%, 41% and 18% in patients with moderate income, and 80%, 50% and 30% in patients with high income, respectively (*p*=0.001, Figure [1](#F1){ref-type="fig"}B). In contrast, the survival was not different between the patients living in the rural/small urban and large urbans, (Median survival, 36 months vs. 41 months, *p*=0.343) (Figure [1](#F1){ref-type="fig"}C).

Socioeconomic factors and patients survival after curative resection
--------------------------------------------------------------------

Totally, there were 623 (42%) patients receiving curative surgical resection of HCC. Interestingly, there was no significant difference of the overall survival of the patients at different education background after curative resection (*p*=0.410, Figure [2](#F2){ref-type="fig"}A). However, after surgical resection, patients with high income showed better prognosis than those with low and moderate income (Median survival, 45 months vs. 37 months and 35 months, *p*=0.003 and *p*=0.015, respectively) (Figure [2](#F2){ref-type="fig"}B). The 1-, 3- and 5-year survival rates after surgery were 89%, 47% and 20% in patients with low income, 88%, 51% and 25% in patients with moderate income, and 92%, 66% and 30% in patients with high income, respectively (*p*=0.010, Figure [2](#F2){ref-type="fig"}B). Moreover, there was no difference of the overall survival of the HCC patients undergoing surgical resection living in large cities and those living in rural places (p=0.111, Figure [2](#F2){ref-type="fig"}C).

Risk factors of HCC patient survival
------------------------------------

To better understand the potential risk factors associated with overall survival of patients, we performed univariate and multivariate analysis by Cox regression model (Table [3](#T3){ref-type="table"}). By univariate analysis, Child-Pugh class B/C, lower education and household income, tumor size larger than 5cm, portal vein tumor thrombosis, and BCLC B, C and D versus 0-A were risk factors associated with poorer long-term survival (all *p*\<0.05, Table [3](#T3){ref-type="table"}), while radical and locoregional treatments were selected as protective factors associated with improved outcome versus supportive treatments (all *p*\<0.05, Table [3](#T3){ref-type="table"}). By multivariate analysis, Child-Pugh class B/C, advanced BCLC stages and lower household income were independently associated with poorer outcome (all *p*\<0.05, Table [3](#T3){ref-type="table"}), while HCC-directed therapies were associated with prolonged survival (all *p*\<0.05, Table [3](#T3){ref-type="table"}).

Discussion
==========

Few studies have been able to examine the influence of socioeconomic status on prognosis of HCC patients. The present study demonstrated that in hospitalized HCC patients, lower education and household income were consistently associated with advanced BCLC stages at diagnosis, less treatment received and poorer long-term survival. It was well accepted that tumor stage and treatments were the most significant factors affecting prognosis of cancer patients. However, socioeconomic status has been neglected in determining screening, diagnosis, major and adjuvant treatments of cancer [@B6], [@B11], [@B12], [@B14]-[@B18]. Several studies using SEER-Medicare database have suggested that persistently poor long-term outcome across HCC population might be partially correlated with underutilization of effective HCC-directed therapies due to sociodemographic and economic factors [@B14]-[@B18]. Underutilization of effective therapies of HCC must be more severe in developing countries, such as China, because of traditional views of incurability of cancers, financial difficulties, and limited healthcare resources.

It is not surprising that education level is closely related to residency place, living habits, income, health insurance available, health care and disease treatments [@B6], [@B11], [@B12], [@B14]-[@B18]. However, due to the historical and social reasons, most patients (902/1485, 61%) in the present study (born before 1960s) were educated at high school level. The National College Entrance Examination of China had been restored since 1977, but with an average enrollment rate less than 5% at the beginning [@B19]. This was also confirmed by that highly educated patients were younger and more male predominant than less educated patients. Interestingly, less education was strongly correlated with more advanced disease, less HCC-target therapies received, higher 90-day mortality and poorer long-term survival. However, after surgical resection, no significant difference of survival was identified in patients at different education level (Figure [2](#F2){ref-type="fig"}A). These findings highlighted that less education was more likely to affect early detection of disease, access to care and choice of treatments of patients [@B16]. Once the patients were diagnosed and surgically treated, education level might be less important than other tumor- and treatment-related factors in affecting HCC outcome.

Household income was closely relevant to, but not determined by education level. Similar to some previous studies on other tumor types [@B6], [@B16], [@B20], patients with low income had more advanced HCC stages, less aggressive treatments received, higher 30-day mortality and poorer long-term survival than those with high income. This association was also manifested in surgical resected HCC patients. Lower household income, but not education level, was identified as independent risk factor of the survival of HCC patients. Patients with low income may be exposed to unhealthy lifestyle or environmental factors, be less intensively screened for HCC, less adherent to any treatments, which lead to more aggressive disease and poorer outcome [@B6], [@B16], [@B20], [@B21].

Although closely correlated to each other, education and income are separate constructs and have different impacts on diagnosis, treatment and prognosis of HCC. While both education and income may be associated with economic resources, education can also reflect noneconomic social characteristics that influence health such as health-related knowledge, acceptance of invasive treatments, and influence one\'s lifestyle [@B21], [@B22]. Income can reflect "ability to pay" in cancer screening, diagnosis, treatment and post-treatment checkup [@B23]. Therefore, more effort should be placed on the lower educated patients, as they could have more risk of late diagnosis, less treatment, higher mortality, as presented in our study. Moreover, efforts from the whole society should be made continuously to support the patients in poverty in cancer screening, diagnosis, and treatments.

Residence of the patients was closely associated with education and income. People with higher education and income are more likely to live in large cities, while those with lower education and income are more likely to live in rural places. This is called "Urban-Rural Gap" which has been noticed for several decades by the whole society and government [@B24]. Interestingly, we found no significant difference of long-term outcome between the patients living in urban and in rural places as whole or after surgical resection. These findings might imply certain socioeconomic changes in the country that the urban-rural gap is narrowing, although the imbalance of education, health and living resources is still huge [@B25]. To reduce the long-standing gap and insuring the rural population against health and economic risk, the Chinese government launched the New Rural Cooperative Medical System in 2003, which covers 95.3% of the rural population of China by 2011 [@B26], [@B27].

There are several limitations of the present study. First, this is a retrospective study conducted in one single center. All the data were collected retrospectively, thus weakened by certain inherent biases. Second, education level was documented only for the patients at admission. However, in China, concealment of diagnosis and prognosis from cancer patients is still common and not all the cancer patients would be fully informed of their diagnosis, treatment and expected prognosis [@B28]. Diagnosis and treatments are usually discussed by family members of the patients and physicians. Therefore, the impact of education level of patients on cancer prognosis would be substantially weakened. However, education level of their families is hard to collect and determine. Third, income is rather complex to measure. Patients and their family members tended to underreport the household income, since some income as bonus might not be reported. Last, the present study has been conducted based on hospitalized patients who were eager to be treated. As we believe, there were still many HCC patients, especially those with low education level and household income, and living in rural places, refusing any invasive treatments in hospital but relying on some folk remedies. Therefore, impacts of socioeconomic status on cancer patient survival should be more significant if taking all the inpatients and outpatients into account.

Conclusion
==========

The present study has shown that HCC patients with less education and lower household income presented with more advanced disease progression at diagnosis, received less effective treatments, and had higher mortality and poorer long-term survival. Intervention strategies targeting patients with less education and lower income should be evaluated to improve the outcomes of HCC by routine screening, early diagnosis and effective treatments. Further studies based on national health database with enrollment of both inpatients and outpatients should be performed, especially in China with great changes in society, law and economics in recent 40 years.
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###### 

Demographic and treatments of the patients at different education level

  -----------------------------------------------------------------------------------------------------
  Variables                Below high school\       High school level\   Above high school\   P value
                           (n=269)                  (n=902)              (n=314)              
  ------------------------ ------------------------ -------------------- -------------------- ---------
  Age (years)              57±11^1,2;1,3^           54±12                55±14                \<0.001

  Male gender              192 (71.4%)^1,2;\ 1,3^   744 (82.5%)          269 (85.7%)          \<0.001

  Child-Pugh class                                                                            0.204

  A                        232 (8.6%)               799 (8.9%)           263 (8.4%)           

  B                        32 (11.9%)               92 (10.2%)           47 (15.0%)           

  C                        5 (1.9%)                 11 (1.2%)            4 (1.3%)             

  Household income\*       ^1,2;\ 1,3^              ^2,3^                                     \<0.001

  ≤ 50,000 CNY             136 (50.6%)              189 (10.9%)          15 (4.8%)            

  50,000-200,000 CNY       110 (40.9%)              529 (58.6%)          123 (39.2%)          

  \>200,000 CNY            20 (7.4%)                178 (19.7%)          176 (56.1%)          

  Residence                ^1,2;\ 1,3^              ^2,3^                                     \<0.001

  Rural/small urban        221 (82.2%)              434 (48.1%)          27 (8.6%)            

  Large urban              48 (17.8%)               468 (51.9%)          287 (91.4%)          

  Hepatitis status         ^1,3^                                                              0.021

  Hepatitis B/C            192 (71.4%)              705 (78.2%)          253 (80.5%)          

  None                     77 (28.6%)               197 (21.8%)          61 (19.4%)           

  First Dept. admitted                                                                        0.408

  Surgery Dept.            166 (61.7%)              690 (76.5%)          260 (82.8%)          

  Internal Medical Dept.   91 (33.8%)               198 (22.0%)          50 (15.9%)           

  Other Dept.              12 (4.5%)                14 (15.5%)           4 (1.3%)             

  BCLC stages              ^1,3^                    ^2,3^                                     0.027

  0-A                      105 (39.0%)              336 (37.3%)          144 (45.9%)          

  B-D                      164 (61.0%)              566 (62.7%)          170 (54.1%)          

  Primary treatments       ^1,2;\ 1,3^              ^2,3^                                     \<0.001

  Liver transplant         2 (0.7%)                 15 (1.7%)            17 (5.4%)            

  Surgical resection       117 (43.5%)              384 (42.6%)          122 (38.9%)          

  Locoregional therapies   117 (43.5%)              437 (48.4%)          148 (47.1%)          

  Supportive treatments    33 (12.3%)               66 (7.3%)            27 (8.6%)            

  30-day mortality         16 (5.9%)                47 (5.2%)            12 (3.8%)            0.475

  90-day mortality         39 (14.5%)^1,2;1,3^      88 (9.8%)            28 (8.9%)            0.045
  -----------------------------------------------------------------------------------------------------

\* Data unavailable in 9 patients; BCLC, Barcelona Liver Cancer; CNY, Chinese Yuan (1 CNY≈0.146 USD); 1,2 *p*\<0.05 when compared between group 1 and 2; 1,3 *p*\<0.05 when compared between group 1 and 3; 2,3 *p*\<0.05 when compared between group 2 and 3.

###### 

Demographic and treatments of the 1476 patients with different household income

  -----------------------------------------------------------------------------------------
  Variables                Low income\          Moderate income\   High income\   P value
                           (n=340)              (n=762)            (n=374)        
  ------------------------ -------------------- ------------------ -------------- ---------
  Age (years)              55±12                54±12^2,3^         56±13          0.020

  Male gender              270 (79.4%)          625 (82.0%)        303 (81.0%)    0.590

  Child-Pugh class         ^1,3^                ^2,3^                             \<0.001

  A                        309 (90.9%)          672 (88.2%)        304 (81.3%)    

  B                        28 (8.2%)            77 (10.1%)         66 (17.6%)     

  C                        3 (0.8%)             13 (1.7%)          4 (1.1%)       

  Residence                ^1,2;\ 1,3^          ^2,3^                             \<0.001

  Rural/small urban        236 (69.4%)          334 (43.8%)        103 (27.5%)    

  Large urban              104 (30.6%)          428 (56.2%)        271 (72.5%)    

  Hepatitis status                                                                0.083

  Hepatitis B/C            249 (73.3%)          595 (78.0%)        299 (80.0%)    

  Others                   91 (26.8%)           167 (21.9%)        75 (20.1%)     

  First Dept. admitted                                                            0.449

  Surgery Dept.            235 (69.1%)          564 (74.0%)        308 (82.4%)    

  Internal Medical Dept.   98 (28.8%)           183 (24.0%)        58 (15.5%)     

  Other Dept.              7 (2.1%)             15 (2.0%)          8 (2.1%)       

  BCLC stages              ^1,2;\ 1,3^                                            0.001

  0-A                      105 (30.9%)          310 (40.7%)        165 (44.1%)    

  B-D                      235 (69.1%)          452 (59.3%)        209 (55.9%)    

  Primary treatments                                                              0.081

  Liver transplant         2 (0.6%)             19 (2.5%)          13 (3.5%)      

  Surgical resection       150 (44.1%)          312 (41.0%)        154 (41.1%)    

  Locoregional therapies   151 (44.4%)          369 (48.4%)        180 (48.1%)    

  Supportive treatments    37 (10.9%)           62 (8.1%)          27 (7.2%)      

  30-day mortality         26 (7.6%)^1,2;1,3^   33 (4.3%)          16 (4.3%)      0.049

  90-day mortality         44 (12.9%)           79 (10.4%)         32 (8.6%)      0.159
  -----------------------------------------------------------------------------------------

BCLC, Barcelona Liver Cancer; 1,2 *p*\<0.05 when compared between group 1 and 2; 1,3 *p*\<0.05 when compared between group 1 and 3; 2,3 *p*\<0.05 when compared between group 2 and 3.

###### 

Univariate and multivariate analysis of the risk factors of survival for hepatocellular carcinoma

  Variables                *n*    events   Univariate analysis   Multivariate analysis                   
  ------------------------ ------ -------- --------------------- ----------------------- --------------- ---------
  Age (years)                                                                                            
  ≤ 50                     560    307      1                                                             
  \> 50                    925    561      1.1 (1.0-1.3)         0.070                                   
  Gender                                                                                                 
  Female                   280    159      1                                                             
  Male                     1205   709      1.0 (0.8-1.2)         0.782                                   
  Child-Pugh class                                                                                       
  A                        1294   733      1                                             1               
  B/C                      191    135      1.9 (1.5-2.2)         \<0.001                 1.6 (1.3-1.9)   \<0.001
  Education                                                                                              
  Above high school        314    168      1                                             1               
  High school level        902    537      1.2 (1.0-1.4)         0.031                   1.2 (0.9-1.5)   0.217
  Below high school        269    163      1.3 (1.1-1.7)         0.007                   1.2 (1.0-1.4)   0.118
  Residence                                                                                              
  Rural/small urban        682    401      1.1 (0.9-1.2)         0.349                                   
  Large urban              803    467      1                                                             
  Household income                                                                                       
  \>200,000 CNY            374    211      1                                             1               
  50,000-200,000 CNY       762    443      1.3 (1.1-1.5)         0.004                   1.2 (1.0-1.4)   0.069
  ≤ 50,000 CNY             340    210      1.4 (1.2-1.7)         0.001                   1.2 (1.0-1.4)   0.036
  Tumor size                                                                                             
  \< 5 cm                  808    448      1                                             1               
  ≥ 5 cm                   677    420      1.3 (1.2-1.5)         \<0.001                 1.1 (0.8-1.3)   0.507
  Tumor number                                                                                           
  ≤ 3                      1296   750      1                                                             
  \> 3                     189    118      1.2 (0.9-1.4)         0.157                                   
  Portal vein thrombosis                                                                                 
  No                       1176   678      1                                             1               
  Yes                      309    190      1.2 (1.0-1.4)         0.048                   1.1 (0.7-1.6)   0.084
  BCLC stages                                                                                            
  0-A                      585    305      1                                             1               
  B                        542    330      1.4 (1.2-1.6)         \<0.001                 2.6 (1.6-4.3)   \<0.001
  C                        318    203      1.5 (1.3-1.8)         \<0.001                 2.8 (1.6-4.9)   \<0.001
  D                        40     30       2.5 (1.7-3.6)         \<0.001                 3.1 (1.9-5.0)   \<0.001
  Primary treatments                                                                                     
  Supportive treatments    126    107      1                                             1               
  Locoregional therapies   702    413      0.2 (0.1-0.2)         \<0.001                 0.2 (0.1-0.2)   \<0.001
  Surgical resection       623    333      0.1 (0.1-0.2)         \<0.001                 0.1 (0.1-0.2)   \<0.001
  Liver transplant         34     15       0.1 (0.1-0.2)         \<0.001                 0.1 (0.1-0.2)   \<0.001

Events, patient death during follow-up; HR, hazard ratio; CI, confidence interval; BCLC, Barcelona Liver Cancer; CNY, Chinese Yuan (1 CNY≈0.146 USD)
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